Focus Feature: Exercise during pandemic linked to better mental health

People who exercised more during the initial lockdown period of the COVID-19 pandemic experienced less anxiety and depression than those who didn’t exercise, according to new research published today. The research also showed that people who spent more time outdoors typically experienced lower levels of anxiety and depression than those who stayed inside.

R&E News and Features

  • Study finds no increased risk of death among COVID-19 vaccine recipients

    COVID-19 vaccine recipients had lower non–COVID-19 death rates than people who weren’t vaccinated, according to Kaiser Permanente research published last month in the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report.  

  • Kaiser Permanente members invited to join flu vaccine study

    Kaiser Permanente Southern California is inviting its members to participate in a nationwide study of how well flu and COVID-19 vaccines are working. It is one of 2 new sites selected by the Centers for Disease Control and Prevention to join the U.S. Flu Vaccine Effectiveness Network, which runs the study.

  • Kaiser Permanente study to assess COVID-19 antibodies in employees, physicians

    A physician investigator in the Southern California Permanente Medical Group received a grant to study antibody responses to COVID-19 vaccination among health care workers. The study will also help learn more about the impact of booster vaccination and the rates of asymptomatic COVID-19 infection among the vaccinated.

In the News

Five questions...

for Dr. Stanley Xu

A senior research scientist biostatistician in the Division of Biostatistics Research in the Department of Research & Evaluation, Dr. Stanley Xu came to R&E in June 2020. He has already led important research, including one study that assessed how health care utilization in Kaiser Permanente Southern California changed due to the pandemic, and another that analyzed mortality after vaccination and confirmed the safety of the COVID-19 vaccines.